EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis

Zhifan Li, Qinqin Ma, Ya Gao, Mengmeng Qu, Jinkui Li, Junqiang Lei

European Radiology · 24.08.2023 · 34 (2) · 930-942

DOI: 10.1007/s00330-023-10155-8 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Radiology, online erschienen am 24.08.2023. Verfasst von Zhifan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Neoadjuvant Therapy, Axilla. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This systematic review examined the diagnostic performance of magnetic resonance imaging (MRI) for assessing axillary lymph node status (ALNS) after neoadjuvant chemotherapy (NAC) in breast cancer patients. METHODS: We searched PubMed, Embase, Cochrane Library, and Web of Science to identify relevant studies and used the QUADAS-2 tool to assess methodological quality of eligible studies. We used STATA version 12.0 to perform data pooling, heterogeneity testing, subgroup analysis, and sensitivity analysis. RESULTS: For the 21 enrolled studies, including 2875 patients, the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were respectively 0.63 (95% CI: 0.53-0.72), 0.75 (95% CI: 0.68-0.81), 2.52 (95% CI: 1.98-3.19), 0.50 (95% CI: 0.39-0.63), and 5.08 (95% CI: 3.38-7.63). The AUC was 0.76 (95% CI: 0.72-0.79). I2 values of sensitivity (I2 = 94.41%) and specificity (I2 = 88.97%) were both > 50%. For the initial positive ALN patients, the pooled sensitivity and specificity were 0.64 (95% CI: 0.53-0.75) and 0.74 (95% CI: 0.64-0.82), respectively. Sensitivity analyses by focusing on studies with MRI performed post-NAC, studies using DCE-MRI, or studies with low risk of bias showed similar results to the primary analyses. CONCLUSION: MRI may have suboptimal diagnostic value in assessing ALNS after NAC for breast cancer patients. Due to the inconsistency of NAC regimens, the variability of axillary surgery, and the lack of time interval between MRI and surgery, further studies are needed to confirm our findings. CLINICAL RELEVANCE STATEMENT: Our study provided the diagnostic value of MRI in assessing axillary lymph node status after neoadjuvant chemotherapy for breast cancer patients. KEY POINTS: • MRI may have suboptimal diagnostic value in assessing axillary lymph node status after NAC for general breast cancer patients. • The initial axillary lymph node status has little impact on the diagnostic efficacy of MRI. • The substantial heterogeneity among studies highlights the need for further studies to provide more high-quality evidence in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMagnetic Resonance ImagingNeoadjuvant TherapyAxillaLymph NodesLymphatic MetastasisSensitivity and SpecificityHumansFemaleChemotherapy, Adjuvant

Stichwörter der Autor:innen

Axillary lymph nodeBreast cancerMagnetic resonance imagingMeta-analysisNeoadjuvant chemotherapy

Autor:innen und Institutionen

  • The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China.
  • Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China.
  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
  • Department of Radiology, the First Hospital of Lanzhou University, Chengguan District, No. 1 Donggang West Road, Lanzhou, 730000, Gansu Province, China.
  • The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, China. leijq2011@126.com.
  • Department of Radiology, the First Hospital of Lanzhou University, Chengguan District, No. 1 Donggang West Road, Lanzhou, 730000, Gansu Province, China. leijq2011@126.com.

Zitieren

APA

Li, Z., Ma, Q., Gao, Y., Qu, M., Li, J., & Lei, J. (2023). Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. European Radiology, 34(2), 930-942. https://doi.org/10.1007/s00330-023-10155-8

Vancouver

Li Z, Ma Q, Gao Y, Qu M, Li J, Lei J. Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. European Radiology. 2023;34(2):930-942. doi:10.1007/s00330-023-10155-8

BibTeX
@article{Li2023,
  author = {Li, Zhifan and Ma, Qinqin and Gao, Ya and Qu, Mengmeng and Li, Jinkui and Lei, Junqiang},
  title = {Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis},
  journal = {European Radiology},
  year = {2023},
  volume = {34},
  number = {2},
  pages = {930--942},
  doi = {10.1007/s00330-023-10155-8}
}
Kostenlos starten →